McKesson — Feb 5, 2025 release

Fiscal 2025 Outlook: • Adjusted Earnings per Diluted Share guidance range raised and narrowed to $32.55 to $32.95, from the previous range of $32.40 to $33.00. • Fiscal 2025 Adjusted Earnings per Diluted Share guidance range indicates 19% to 20% growth compared to prior year. • The Company does not forecast GAAP earnings per diluted share 1 . "McKesson reported strong third quarter operational results with broad-based Revenue growth of 18% and Adjusted Operating Profit growth of 16%. Our performance reflects the strength and momentum across the enterprise. I would like to thank the McKesson employees for their continued dedication to advancing our mission," said Brian Tyler, chief executive officer. "We remain committed to our enterprise growth strategy, including our growth pillars within oncology and biopharma services. This strategy has enabled our strong results and is a foundation for balanced growth and value creation. Based on our third quarter performance, we are raising and narrowing our guidance range for fiscal 2025 Adjusted Earnings per Diluted Share to $32.55 to $32.95." Mr. Tyler added, "We are also pleased to announce the signing of a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, in support of our leadership in community practice management and specialty solutions. With this transaction, we intend to develop a leading platform for retinal care, delivering differentiated so